These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 39087462
1. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients. Bae EK, Chandran MM, Everitt MD, Benz E, Bock M. Clin Transplant; 2024 Aug; 38(8):e15417. PubMed ID: 39087462 [Abstract] [Full Text] [Related]
2. The use of once-daily LCP-Tacrolimus with adolescent and young adult solid organ transplant recipients. Householder S, Ramakrishnan A, Chen JK, Gorsch L, Tsapepas D, Lobritto S, Rundle A, Vittorio JM. Pediatr Transplant; 2024 Jun; 28(4):e14777. PubMed ID: 38702932 [Abstract] [Full Text] [Related]
3. Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients. Choi D, Thaker S, West-Thielke P, Elmasri A, Chan C. Eur J Gastroenterol Hepatol; 2021 Aug 01; 33(8):1124-1128. PubMed ID: 34213506 [Abstract] [Full Text] [Related]
4. Impact of converting adult kidney transplant recipients with high tacrolimus variability from twice daily immediate release tacrolimus to once daily LCP-Tacrolimus. Taber DJ, Bartlett F, Patel N, Sprague T, Patel S, Newman J, Andrade E, Rao N, Salas MAP, Casey M, Dubay D, Rohan V. Clin Transplant; 2023 May 01; 37(5):e14941. PubMed ID: 36809653 [Abstract] [Full Text] [Related]
6. Evaluation of Tacrolimus Concentrations and Clinical Outcomes Between Extended and Immediate Release Formulations in Kidney Transplant. Naguib H, Katz-Greenberg G, Harris M, Gommer J, Yang LZ, Erkanli A, Byrns J. J Pharm Pract; 2024 Dec 01; 37(6):1283-1290. PubMed ID: 38683344 [Abstract] [Full Text] [Related]
7. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients. Kim SH, Lee SD, Kim YK, Park SJ. Hepatobiliary Pancreat Dis Int; 2015 Aug 01; 14(4):374-9. PubMed ID: 26256081 [Abstract] [Full Text] [Related]
8. The use of LCP-Tacrolimus (Envarsus XR) in simultaneous pancreas and kidney (SPK) transplant recipients. Torabi J, Konicki A, Rocca JP, Ajaimy M, Campbell A, Azzi Y, Pynadath C, Liriano-Ward L, Akalin E, Kinkhabwala M, Graham JA. Am J Surg; 2020 Apr 01; 219(4):583-586. PubMed ID: 32122660 [Abstract] [Full Text] [Related]
9. Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial. Faravardeh A, Akkina S, Villicana R, Guerra G, Moten MA, Meier-Kriesche U, Stevens DR, Patel SJ, Bunnapradist S. Ann Transplant; 2021 Apr 16; 26():e929535. PubMed ID: 33859155 [Abstract] [Full Text] [Related]
12. Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study. Lehner LJ, Reinke P, Hörstrup JH, Rath T, Suwelack B, Krämer BK, Budde K, Banas B. Clin Transplant; 2018 Jan 16; 32(1):. PubMed ID: 29052906 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of Envarsus in pediatric kidney transplant recipients - phase 1 pilot conversion study. Kim JJ, Lawless L, Marshall D, Maxted A, Lunn A, Mallik M, Williams A. Pediatr Transplant; 2024 Mar 16; 28(2):e14703. PubMed ID: 38433334 [Abstract] [Full Text] [Related]
14. Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial. Suwelack B, Bunnapradist S, Meier-Kriesche U, Stevens DR, Procaccianti C, Morganti R, Budde K. Ann Transplant; 2020 Jul 28; 25():e923278. PubMed ID: 32719307 [Abstract] [Full Text] [Related]
15. Extended-release tacrolimus dosing and outcomes in pediatric and young adult transplant recipients - A single-center experience. Huang X, Hapgood K, Allan K, Pruette C, Goswami E. Pediatr Transplant; 2024 Feb 28; 28(1):e14611. PubMed ID: 37735900 [Abstract] [Full Text] [Related]
16. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts. Considine A, Tredger JM, Heneghan M, Agarwal K, Samyn M, Heaton ND, O'Grady JG, Aluvihare VR. Liver Transpl; 2015 Jan 28; 21(1):29-37. PubMed ID: 25312292 [Abstract] [Full Text] [Related]
17. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial. Rostaing L, Bunnapradist S, Grinyó JM, Ciechanowski K, Denny JE, Silva HT, Budde K, Envarsus Study Group. Am J Kidney Dis; 2016 Apr 28; 67(4):648-59. PubMed ID: 26717860 [Abstract] [Full Text] [Related]
18. Comparing the pharmacokinetics of extended-release tacrolimus (LCP-TAC) to immediate-release formulations in kidney transplant patients. Tan T, Bunnapradist S. Expert Opin Drug Metab Toxicol; 2021 Oct 28; 17(10):1175-1186. PubMed ID: 34459696 [Abstract] [Full Text] [Related]
19. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients. Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C. Transplant Proc; 2012 Jan 28; 44(1):121-3. PubMed ID: 22310594 [Abstract] [Full Text] [Related]
20. Clinical Experience with Extended-Release Tacrolimus in Older Adult Kidney Transplant Recipients: A Retrospective Cohort Study. January SE, Hagopian JC, Nesselhauf NM, Progar K, Horwedel TA, Santos RD. Drugs Aging; 2021 May 28; 38(5):397-406. PubMed ID: 33755934 [Abstract] [Full Text] [Related] Page: [Next] [New Search]